CPI Start-Up PolyPhotonix Announced as National Business Awards Finalist

CPI start-up company PolyPhotonix has been shortlisted as a finalist for the prestigious Innovation Award at the 2014 National Business Awards. Competing against hundreds of entries, PolyPhotonix has reached the final shortlist of the UK’s 10 most innovative companies. The gala awards dinner will be held Nov. 11 in London.

PolyPhotonix’s entry is centred around the novel phototherapy Sleep Mask termed Noctura 400, which is part of a monitored ophthalmic treatment for Diabetic Retinopathy. It is non-invasive, and has been designed to be worn at night to deliver a precise dose of OLED light therapy during a patient’s normal hours of sleep as part of an on-going, primary care treatment. Independent health economists working with the NHS estimate that the Noctura treatment could deliver a saving in excess of £1 billion a year to the NHS on adoption of the treatment.

“PolyPhotonix is delighted to be shortlisted for the Innovation Award at the 2014 National Business Awards,” said Richard Kirk, CEO of PolyPhotonix. “The recognition represents the hard work that the team has put into creating a revolutionary therapy that will transform lives.”